<p><i>P<sub>het</sub></i>: test for heterogeneity; OR: odds ratio; CI: confidence interval; N: number of comparisons.</p><p>The figures given in bold indicate statistically significant values.</p
<p>N: number of studies; OR: odds ratio; P<sub>h</sub>: p value for heterogeneity; <b>*OR</b> with s...
<p>Meta-analysis for the association between Fas -1377 G/A polymorphism and cancer risk by fixed-eff...
<p>P-values for ORs; <i>Ph</i> values of Q-test for heterogeneity test; I<sup>2</sup> refers to the ...
polymorphisms and cancer risk in a meta-analysis with eligible published studies. rs4986791. polymo...
<p>Meta-analysis results for the four polymorphisms and breast cancer risk. (OR, odds ratio; CI, con...
<p>Abbreviations: OR, odds ratio; CI, confidence interval; <i>I</i><sup>2</sup>, Cochran's c–based Q...
<p>Meta-analysis of <i>LTA</i> rs2229094 polymorphism and cancer risk stratified by cancer type.</p
<p>OR: odds ratio; CI: confidence interval; I<sup>2</sup>, measure to quantify the degree of heterog...
<p>The results were computed by omitting each study (left column) in turn. Meta-analysis random-effe...
<p>OR: odds ratio; CI: confidence interval; I<sup>2</sup>, measure to quantify the degree of heterog...
polymorphisms and cancer risk, but the findings remain inconclusive. = 0.046). No publication bias ...
<p>HB: hospital based; PB: population based; OR: odds ratio; CI: confidence interval; <i>P</i>: p va...
and cancer risk is uncertain. Therefore, we conducted a meta-analysis of the current literature to ...
genetic polymorphism rs2853676 is associated with cancer risk, but presented inconsistent results. ...
<p>Meta-analysis for the association between Fas -1377 G/A polymorphism and cancer risk by fixed-eff...
<p>N: number of studies; OR: odds ratio; P<sub>h</sub>: p value for heterogeneity; <b>*OR</b> with s...
<p>Meta-analysis for the association between Fas -1377 G/A polymorphism and cancer risk by fixed-eff...
<p>P-values for ORs; <i>Ph</i> values of Q-test for heterogeneity test; I<sup>2</sup> refers to the ...
polymorphisms and cancer risk in a meta-analysis with eligible published studies. rs4986791. polymo...
<p>Meta-analysis results for the four polymorphisms and breast cancer risk. (OR, odds ratio; CI, con...
<p>Abbreviations: OR, odds ratio; CI, confidence interval; <i>I</i><sup>2</sup>, Cochran's c–based Q...
<p>Meta-analysis of <i>LTA</i> rs2229094 polymorphism and cancer risk stratified by cancer type.</p
<p>OR: odds ratio; CI: confidence interval; I<sup>2</sup>, measure to quantify the degree of heterog...
<p>The results were computed by omitting each study (left column) in turn. Meta-analysis random-effe...
<p>OR: odds ratio; CI: confidence interval; I<sup>2</sup>, measure to quantify the degree of heterog...
polymorphisms and cancer risk, but the findings remain inconclusive. = 0.046). No publication bias ...
<p>HB: hospital based; PB: population based; OR: odds ratio; CI: confidence interval; <i>P</i>: p va...
and cancer risk is uncertain. Therefore, we conducted a meta-analysis of the current literature to ...
genetic polymorphism rs2853676 is associated with cancer risk, but presented inconsistent results. ...
<p>Meta-analysis for the association between Fas -1377 G/A polymorphism and cancer risk by fixed-eff...
<p>N: number of studies; OR: odds ratio; P<sub>h</sub>: p value for heterogeneity; <b>*OR</b> with s...
<p>Meta-analysis for the association between Fas -1377 G/A polymorphism and cancer risk by fixed-eff...
<p>P-values for ORs; <i>Ph</i> values of Q-test for heterogeneity test; I<sup>2</sup> refers to the ...
DOI
Add to ORKG